|
|
|
| Anti-Oxid Optimizer |
| by Jarrow Formulas
|
|
Size :
90 Tabs
SKU # :
ANT
Prod. ID:
1607
UPC Code:
790011010012
Retail Price:
$19.95
Discount:
27%
Our Price:
$14.47
|
|
|
|
|
 |
|
|
|
|
 |
 |
|
|
 |
 |
 |
Description of Anti-Oxid Optimizer
|
|
ANTIOXIDANT OPTIMIZER is an outstanding, synergistic blend of water and lipid soluble antioxidants, including:
Lutein and Lycopene (Lyc-O-Mato) are prominent carotenoids, protecting eyes, cardiovascular system, breast, cervical, and other tissues and organs.
Green Tea 5:1 extract (45% polyphenols including 30% catechins) are the building blocks of OPCs and powerful antioxidants.
Silymarin flavonoids support liver function.
OleaSelect Olive Fruit Polyphenols consists of cardioprotective antioxidant flavonoids - tyrosol, hydroxytyrosol, and verbascosides.
LeucoSelect Grape Seed OPCs promote healthy circulation and capillary integrity.
Gamma Tocopherol is a form of vitamin E that protects against reactive nitrogen compounds.
|
|
 |
 |
 |
Ingredients of Anti-Oxid Optimizer
|
|
 |
| Supplement Facts |
Serving Size 3 Tablets |
|
| Vitamin C (ascorbic acid) |
250 mg |
417% |
| Gamma Tocopherol |
100 mg |
† |
| Lutein |
5 mg |
† |
| Lycopene (100% Natural Lyc-O-Mato) |
2 mg |
† |
| Grape Seed OPCs (LeucoSelect) |
50 mg |
† |
| Grapeskin Extract (30% Polyphenols) |
150 mg |
† |
| Silymarin 80% (Milk Thistle seed 30:1 concentrate) |
80 mg |
† |
| Olive Fruit Polyphenols (OleaSelect) |
30 mg |
† |
| Green Tea 5:1 concentrate (45% polyphenols) |
250 mg |
† |
| Curcumin (Tumeric Root 18:1 concentrate) |
300 mg |
† |
| Freeze Dried Ginger 6:1 |
200 mg |
† |
|
| Other Ingredients: Cellulose, calcium phosphate, modified cellulose gum, stearic acid, vegetable magnesium stearate and silicon dioxide. |
†: Daily value not established.
|
|
|
|
 |
 |
 |
Suggested Use for Anti-Oxid Optimizer
|
|
|
Take 1 to 3 tablets per day with meals, or as directed by your qualified health consultant.
|
|
 |
 |
 |
Warning for Anti-Oxid Optimizer
|
|
|
Keep out of the reach of children.
|
|
 |
 |
 |
|
|
|
|
|
 |
 |
 |
|
|